Previous 10 | Next 10 |
NEW YORK, NY, April 01, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced its 2021 Annual Meeting of Shareholders (“Annual Meeting”), with respect to Pro...
Enzo Biochem (NYSE:ENZ) named Kara Cannon as COO from her previous role as chief commercial officer. David Bench, current CFO, has been named to the additional roles of SVP, treasurer, and corporate secretary. Both appointments are effective immediately. ENZ is actively engaged in a search to...
NEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced two key appointments to its new management structure. The Company announced Kara Cannon has b...
Enzo Biochem, Inc. (ENZ) Q2 2022 Earnings Conference Call March 14, 2022 4:30 PM ET Company Participants David Holmes - Investor Relations Hamid Erfanian - Chief Executive Officer David Bench - Chief Financial Officer Conference Call Participants Paul Nouri - Noble Equity Fund Christian Schwa...
Enzo Biochem press release (NYSE:ENZ): FQ2 Non-GAAP EPS of $0.03. Revenue of $34.05M (+8.2% Y/Y). Shares +11.3%. For further details see: Enzo Biochem Non-GAAP EPS of $0.03, revenue of $34.05M
Second quarter revenue of $34.0 million increased 28% sequentially and 8% year-over-year compared to FY2021 Enzo Biochem posted highest quarterly revenue in history of the Company Enzo Life Science revenue reached $10.4 million, an increase of 39% year over yea...
ACHR, AGRO, ALT, ASLE, BRT, COUP, CVGW, DLO, ENZ, FINV, GTLB, HOFV, LIFE, LRFC, MHLD, MTN, NOAH, OTC:NWHUF, OPTT, PEI, SLGG, SMFR, WPRT, YALA For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Monday's close
NEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum , Tuesday, March 22, 2022 at 3:00pm Eas...
Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY, March 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report second quarter 2022 financial results on Monday, March ...
NEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointments of Hamid Erfanian and Bradley Radoff to the Company’s Board of Directo...
News, Short Squeeze, Breakout and More Instantly...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's...
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fis...